Core Scientific (CORZ) Free Cash Flow (2021 - 2026)

Core Scientific (CORZ) has 6 years of Free Cash Flow data on file, last reported at -$139.3 million in Q1 2026.

• Quarterly Free Cash Flow fell 8.0% year-over-year to -$139.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$461.1 million (down 126.93% YoY) and the FY2025 annual result came in at -$450.8 million, down 765.74% from the prior year.
• Free Cash Flow retreated to -$139.3 million in Q1 2026 per CORZ's latest filing, from -$121.7 million in the prior quarter.
• The five-year high for Free Cash Flow was $178.3 million in Q4 2022, with the low at -$139.3 million in Q1 2026.
• Average Free Cash Flow over 5 years is -$33.5 million, with a median of -$26.1 million recorded in 2022.
• Year-over-year, Free Cash Flow surged 170.44% in 2023 and slumped 7656.62% in 2025.
• Core Scientific's Free Cash Flow stood at $178.3 million in 2022, then sank by 94.36% to $10.1 million in 2023, then tumbled by 248.67% to -$15.0 million in 2024, then slumped by 714.14% to -$121.7 million in 2025, then decreased by 14.47% to -$139.3 million in 2026.
• Business Quant data shows CORZ's Free Cash Flow at -$139.3 million in Q1 2026, -$121.7 million in Q4 2025, and -$112.7 million in Q3 2025.